Fang, Zijian
Corbizi Fattori, Giuditta
McKerrell, Thomas http://orcid.org/0000-0003-4235-0650
Boucher, Rebecca H.
Jackson, Aimee
Fletcher, Rachel S.
Forte, Dorian http://orcid.org/0000-0002-8443-605X
Martin, Jose-Ezequiel http://orcid.org/0000-0002-0051-8868
Fox, Sonia
Roberts, James
Glover, Rachel
Harris, Erica
Bridges, Hannah R. http://orcid.org/0000-0001-6890-6050
Grassi, Luigi
Rodriguez-Meira, Alba
Mead, Adam J. http://orcid.org/0000-0001-8522-1002
Knapper, Steven http://orcid.org/0000-0002-6405-4441
Ewing, Joanne
Butt, Nauman M.
Jain, Manish
Francis, Sebastian
Clark, Fiona J.
Coppell, Jason
McMullin, Mary F. http://orcid.org/0000-0002-0773-0204
Wadelin, Frances
Narayanan, Srinivasan
Milojkovic, Dragana
Drummond, Mark W.
Sekhar, Mallika
ElDaly, Hesham
Hirst, Judy http://orcid.org/0000-0001-8667-6797
Paramor, Maike http://orcid.org/0000-0002-8523-3588
Baxter, E. Joanna http://orcid.org/0000-0002-5946-5238
Godfrey, Anna L.
Harrison, Claire N.
Méndez-Ferrer, Simón http://orcid.org/0000-0002-9805-9988
Article History
Received: 13 March 2023
Accepted: 2 November 2023
First Online: 25 November 2023
Competing interests
: C.N.H. reports funded research from Novartis; speaker fees from Novartis, Janssen, CTI, Celgene, and Medscape; and advisory board membership for Incyte, CTI, Sierra Oncology, Novartis, Celgene, Roche, AOP pharma, Geron, and AstraZeneca. A.J.M. reports funded research from Novartis, Celgene/BMS and consultancy for Abbvie, CTI, and Gilead. S.K. reports funded research and advisory board membership for Novartis. J.E. reports advisory board membership for Novartis, Incyte and Celgene/BMS. M.F.M. reports consultancies for Celgene and BMS; and advisory board membership for Novartis, Jazz, and Abbvie. S.N. reports speaker fees for Takeda, Celgene, Novartis, MSD and Alexion. D.M. reports consultancy for Incyte, Pfizer, Novartis, and Bristol-Myers Squibb. M.W.D. reports funded research from Blueprint Medicine Corporation and advisory board membership for Bristol-Myers Squibb, Novartis, Gilead, Pfizer, Jazz, Takeda, and Astellas. The remaining authors declare no competing financial interests. A.L.G. reports speaker fees from Novartis and advisory board membership AOP pharma and BMS.